Metabolic Characterization of Cerebrospinal Fluid for Patients With Autoimmune Encephalitis: A Preliminary Study
2025

Metabolic Characterization of Cerebrospinal Fluid in Autoimmune Encephalitis

Sample size: 35 publication 10 minutes Evidence: moderate

Author Information

Author(s): Li Xiaolong, Qin Xiaoxiao, Xie Yuan, Wang Lingyun, Wang Jinwen, Ji Shushen, Jiang Huihui, Wang Qun

Primary Institution: Xiangyang No. 1 People's Hospital, Hubei University of Medicine

Hypothesis

This study aims to explore metabolic characterization in cerebrospinal fluid from individuals with autoimmune encephalitis to understand its pathophysiology.

Conclusion

Distinct metabolic profiles were found in the cerebrospinal fluid of patients with autoimmune encephalitis compared to control subjects, indicating potential biomarkers and insights into the disease's pathophysiology.

Supporting Evidence

  • 21 potential biomarkers were identified from the metabolic analysis.
  • Levels of pyruvic acid and oxoglutaric acid were significantly elevated in patients with autoimmune encephalitis.
  • Distinct metabolic profiles suggest mitochondrial dysfunction in autoimmune encephalitis.
  • Seven differential metabolites were identified in the tissue-based assay group.
  • Disordered pathways related to fatty acid metabolism were observed.

Takeaway

Doctors studied the fluid around the brain and spine of people with a brain disease to find clues about what causes it.

Methodology

The study used ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC–MS/MS) to analyze cerebrospinal fluid metabolites from patients with autoimmune encephalitis and control subjects.

Potential Biases

There may be biases due to the small sample size and differences in age between groups.

Limitations

The sample sizes for both cohorts were relatively small, which may limit the robustness of the findings.

Participant Demographics

The study included 35 patients, with 18 diagnosed with autoimmune encephalitis and 17 control subjects without neurological diseases.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1111/cns.70203

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication